[go: up one dir, main page]

PE20040623A1 - Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa - Google Patents

Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa

Info

Publication number
PE20040623A1
PE20040623A1 PE2003000527A PE2003000527A PE20040623A1 PE 20040623 A1 PE20040623 A1 PE 20040623A1 PE 2003000527 A PE2003000527 A PE 2003000527A PE 2003000527 A PE2003000527 A PE 2003000527A PE 20040623 A1 PE20040623 A1 PE 20040623A1
Authority
PE
Peru
Prior art keywords
combination
acetylcholine esterase
nmda antagonist
esterase inhibitors
inhibitors
Prior art date
Application number
PE2003000527A
Other languages
English (en)
Inventor
Lars Lykke Thomsen
Anders Gersel Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28051666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20040623(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PE20040623A1 publication Critical patent/PE20040623A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: (A) UNO O MAS INHIBIDORES DE ACELTILCOLINESTERASA O UNA SAL DEL MISMO TAL COMO TACRINA, DONEPEZIL, RIVASTIGMINA, ENTRE OTROS; (B) UNO O MAS ANTAGONISTAS DE NMDA COMO MEMANTINA. DONDE (A) Y (B) PUEDEN HALLARSE EN EL MISMO VEHICULO O NO; Y PUEDEN SER ADMINISTRADOS SIMULTANEAMENTE O CONCOMITANTEMENTE. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DEL ALZHEIMER, DEL DETERIORO COGNITIVO LEVE O LA DEMENCIA
PE2003000527A 2002-05-31 2003-05-29 Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa PE20040623A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200200844 2002-05-31

Publications (1)

Publication Number Publication Date
PE20040623A1 true PE20040623A1 (es) 2004-09-11

Family

ID=28051666

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000527A PE20040623A1 (es) 2002-05-31 2003-05-29 Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa

Country Status (9)

Country Link
KR (1) KR101016927B1 (es)
CN (1) CN1655793A (es)
AR (1) AR040121A1 (es)
CA (1) CA2426492C (es)
EA (1) EA007632B1 (es)
IS (1) IS7558A (es)
PE (1) PE20040623A1 (es)
UA (1) UA82480C2 (es)
ZA (1) ZA200409147B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA107653U (uk) 2012-10-01 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
CN118239847A (zh) * 2014-05-29 2024-06-25 广州喜鹊医药有限公司 具有神经保护作用的金刚烷胺硝酸酯化合物的制备方法
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR20210072569A (ko) 2019-12-09 2021-06-17 주식회사 종근당 도네페질 및 메만틴을 포함하는 복합 제제

Also Published As

Publication number Publication date
EA007632B1 (ru) 2006-12-29
EA200401617A1 (ru) 2005-06-30
AR040121A1 (es) 2005-03-16
KR20050024296A (ko) 2005-03-10
IS7558A (is) 2004-11-26
CA2426492A1 (en) 2003-09-16
CA2426492C (en) 2006-10-03
ZA200409147B (en) 2006-06-28
KR101016927B1 (ko) 2011-02-28
UA82480C2 (uk) 2008-04-25
CN1655793A (zh) 2005-08-17

Similar Documents

Publication Publication Date Title
TR200102647T2 (tr) Doğurganlığı geliştirmeye mahsus bileşimler
CL2010001160A1 (es) Compuestos derivados de 3,8-diazabiciclo[4.2.0]octano y 3,6-diazabiciclo[3.2.0]heptano; composicion farmaceutica; moduladores del reeptor de la orexina, utiles en el tratamiento del insomnio.
UY26482A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
PA8587101A1 (es) Nuevos derivados de dihidropirimido [4,5-d] pirimidinona sustituida por amiino, fabricacion y uso de los mismos como agentes farmaceuticos
CO4560552A1 (es) Antagonistas de receptores de taquicininas no peptidicos
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
DOP2002000545A (es) Moléculas pequeñas para el tratamiento del crecimiento celular anormal
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
SG165315A1 (en) Alpha2c adrenoreceptor agonists
PE20110431A1 (es) Etexilato de dabigatran o una sal del mismo
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
CL2010001123A1 (es) Uso de piridin-3-ilmetil docosahexanoato para preparar un medicamento util para la prevencion y/o el tratamiento de enfermedades cardiovasculares (divisional solicitud 1848-07).
PA8579801A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
NI200700292A (es) Amidas novedosas derivadas de acidos piperidin carboxilicos
BRPI0513317A (pt) ciclosporinas para tratar doença de alzheimer
ES2174921T3 (es) Inhibidores de la proteasa del vih.
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
DE60101213D1 (de) Pharmazeutische zusammensetzung enthaltend einen squalenepoxidasehemmer und einen makrolid-immunomodulator
CL2007000380A1 (es) Compuestos derivados de pirrolo[3,4-c]pirrol sustituidos; antagonista de los receptores ccr5 de quimioquinas ccr5,composicion farmaceutica;y su uso en el tratamiento o prevencion de infecciones por virus de la inmunodeficiencia humana (vih-1)o pra tratar el sida o el arc.
PA8577701A1 (es) Polipeptido t20 pegilado
PE20040623A1 (es) Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa
AR029155A1 (es) Combinacion y uso de la misma en la fabricacion de un medicamento util para tratar afecciones cardiovasculares
PE20011049A1 (es) Combinacion de farmacos para el tratamiento de la depresion y trastornos relacionados que comprenden mirtazapina

Legal Events

Date Code Title Description
FC Refusal